[Cholecystokinin-B/gastrin receptor is a novel molecular probe for human small cell lung cancer]

Y Matsumori1, N Katakami, N Iwata

  • 1Department of Medicine, Kobe University School of Medicine.

Insights

The CCK-B/gastrin receptor is selectively found in small cell lung cancer (SCLC). This discovery offers a new molecular marker for diagnosing SCLC using biopsy samples.

Area of Science:

  • Molecular biology
  • Oncology
  • Gastroenterology

Context:

  • The CCK-B/gastrin receptor is a serpentine G protein-coupled receptor.
  • Previous research involved cloning CCK-B/gastrin receptor cDNAs.

Purpose:

  • To investigate the presence of CCK-B/gastrin receptor mRNA in different types of lung cancer.
  • To determine if CCK-B/gastrin receptor can serve as a diagnostic marker for small cell lung cancer (SCLC).

Summary:

  • CCK-B/gastrin receptor mRNA was detected in all 10 small cell lung cancer (SCLC) cases using RT-PCR.
  • The receptor mRNA was found in only one of 13 squamous cell carcinomas and 21 adenocarcinomas of the lung.
  • This selective expression suggests CCK-B/gastrin receptor is a potential biomarker for SCLC.

Impact:

  • Provides a novel molecular marker for the diagnosis of small cell lung cancer (SCLC).
  • Enables diagnosis using readily available biopsy specimens.
  • May lead to earlier and more accurate SCLC detection and treatment.

Related Concept Videos